FDA Approves Zevtera for ABSSSI: Here’s What Dermatologists Should Know
The U.S. Food and Drug Administration (FDA) approved ceftobiprole medocaril sodium (Zevtera, Basilea Pharmaceutica Ltd) for adult patients with acute bacterial skin and skin structure infections (ABSSSI). It’s IV only Ceftobiprole is a fifth-generation cephalosporin for intravenous (IV) use only. Ceftobiprole confers a wide spectrum of rapid bactericidal activity Ceftobiprole confers a wide spectrum of rapid […]